The U.S. Oncology business is preparing for the potential U.S. launch of an mRNA-based individualized neoantigen therapy for early-stage melanoma, developed through an alliance partnership. The role designs, integrates, and continuously improves operational processes that enable delivery of the Intismeran treatment journey. It serves as the primary commercial representative across cross-functional operational teams and external partners, aligning workflows, governance, stakeholder activities, and supporting technologies across the end-to-end treatment journey. As process architect for the treatment journey, this leader drives integration across treatment sites, pathology laboratories, sequencing providers, manufacturing partners, distributors, alliance stakeholders, and internal teams. The position establishes governance, addresses operational barriers, improves customer and treatment site experiences, and ensures processes, stakeholder interactions, and systems work together to support treatment completion, operational excellence, and future scalability. The role reports to the Director, Individualized Therapy Operations.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director